Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 0.33% today. In the last week its performance is 10.56%, and 1.80% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 332.5, so today’s gain of 0.33% is a significant step towards its target price. The GAP today is therefore 0.02%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 63052.6, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.70%.
At the current price of 288.72, it has a dividend yield of *TBA, and its target price is 332.5. This is with a profit margin of 34.00%, and total debt/equity of 0. Biogen Inc. (NASDAQ:BIIB) has a P/E of 16.8, as well as a forward P/E of 13.82.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 5.12%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 9.01%.
Performance for the year is -25.26%. Since its IPO date on 9/17/1991, the total performance to date is -6.06%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 874602, while its average volume is 1870.29. Whilst the total gain today was 0.33%, it did have a day high of -1.36%.
Volatility for this week has been at 2.47%, and 2.21% for the month. The 52-week low for Biogen Inc., BIIB has been 29.46%, while the 52-week-high has reached -27.13%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 1.86, and the P/S is 5.61, along with a P/B of 5.53. Meanwhile it has a p/cash of *TBA.